"This analysis explores the critical shifts in the sector, highlighting a projected growth trajectory driven by technological integration and changing consumer dynamics."

According to analysts at Vantage Market Research, the United States Brachytherapy Market size is worth USD 0.56 Billion in 2025 and is projected to reach USD 1.12 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 7.1% from 2026 to 2035. Key trends include growing adoption of high-dose rate brachytherapy, expansion of image-guided radiation therapy, increasing use of electronic brachytherapy, advanced treatment planning software, AI-enabled oncology workflows, rising cancer treatment demand, integrated imaging systems, and growing emphasis on lifecycle service and precision radiation technologies.

United States Brachytherapy Market Overview

The United States Brachytherapy Market is witnessing sustained expansion as hospitals, cancer treatment centers, and specialty oncology providers increasingly invest in precision radiation therapies that deliver localized treatment while limiting exposure to surrounding healthy tissues. Brachytherapy remains an established component of radiation oncology, supporting treatment across prostate, gynecological, breast, skin, head and neck, and other cancer indications.

Healthcare providers are modernizing radiation oncology departments through investments in image-guided treatment systems, advanced afterloaders, treatment planning software, imaging technologies, and workflow automation. High-Dose Rate (HDR) brachytherapy continues to represent the leading treatment type because of its established clinical use, shorter treatment sessions, and compatibility with modern image-guided treatment protocols.

The growing adoption of digital treatment planning and artificial intelligence-enabled technologies is further transforming clinical workflows. Oncology providers increasingly seek integrated solutions capable of improving treatment precision, reducing planning complexity, supporting automated quality assurance, and strengthening operational efficiency.

The market also benefits from sophisticated healthcare infrastructure, established oncology networks, academic research activity, and continued investment in cancer treatment modernization. As healthcare organizations prioritize precision medicine and value-based care, procurement decisions increasingly emphasize total ownership costs, software integration, service support, isotope supply reliability, and long-term technology performance.

Elekta AB Enhanced Image-Guided Radiation Oncology Capabilities

April 2025 — Elekta AB introduced enhanced image-guided workflow capabilities for radiation oncology platforms, supporting improved treatment precision and operational productivity across advanced radiation therapy environments.

Key Takeaways from the Report

Rising cancer incidence and expanding precision oncology programs are strengthening demand for localized radiation treatment technologies across the United States.
High-Dose Rate (HDR) brachytherapy remains the leading treatment type due to established clinical protocols, shorter treatment sessions, and widespread adoption across major oncology centers.
Electronic brachytherapy is emerging as a fast-expanding technology as healthcare providers seek flexible radiation treatment systems with simplified isotope handling requirements.
Prostate cancer remains the leading application, supported by established treatment protocols, extensive clinical experience, and favorable therapeutic outcomes.
Image-guided brachytherapy continues gaining importance as hospitals integrate advanced imaging, treatment planning, and navigation technologies to improve procedural accuracy.
Treatment planning software is becoming increasingly important as oncology departments adopt artificial intelligence, automation, adaptive planning, and digital workflow management.
Hospitals remain the dominant end-user category because of their comprehensive oncology infrastructure, multidisciplinary teams, and ability to support advanced radiation treatment platforms.
Cancer treatment centers are expanding investments in specialized brachytherapy capabilities as dedicated oncology providers increase treatment capacity and modernize technology infrastructure.
Healthcare procurement strategies increasingly emphasize lifecycle service agreements, software upgrades, clinical training, cybersecurity, equipment reliability, and isotope supply continuity.
Artificial intelligence and workflow automation are creating new opportunities for manufacturers developing intelligent treatment planning, quality assurance, and clinical decision-support solutions.
Continued investments in cancer research, precision medicine, and advanced oncology infrastructure are expected to support long-term industry development through 2035.

Top Players

GE HealthCare
Siemens Healthineers
Elekta AB
Varian Medical Systems
Eckert & Ziegler
Isoray Medical Inc.
BEBIG Medical
iCAD Inc.
Sun Nuclear Corporation
CIVCO Medical Solutions
Theragenics Corporation
Boston Scientific Corporation

Report Coverage

Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional market landscapes, and evaluate the impact of major events such as the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.

Latest Announcement

November 2025 — Eckert & Ziegler increased isotope production capacity supporting North American healthcare providers, strengthening supply reliability for radiation oncology applications and reinforcing the infrastructure supporting advanced brachytherapy procedures.